Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has obtained the CE mark. Veye Chest is now cleared to detect and characterize lung nodules in CT images in clinical practice across the EU.
Imaging plays a central role in the diagnosis of lung cancer, which often presents as pulmonary nodules on chest CT scans. Detecting and characterizing these nodules can be a trying and time-consuming task for radiologists who are expected to report nodules as small as 5mm. As a result of their small size and resemblance to normal lung structures, detecting these pulmonary nodules is often time-consuming and susceptible to errors.
Veye Chest leverages the power of artificial intelligence to assist radiologists in the detection and reporting of pulmonary nodules. It integrates seamlessly into the radiologists’ workflow. Veye Chest provides accurate, prompt and valuable nodule reports within radiologists’ existing workstations.
Building on the CE-marked software for the automated detection of pulmonary nodules, Veye Chest adds clinically approved features for fully automated nodule diameter and volume measurement, growth rate and composition.
For more information: aidence.com
April 24, 2024 
